RESEARCHER PROFILE

Mutaz Al-Khnifsawi

University of Al-Qadisiyah

Lipoproteins and Cardiovascular HealthLipid metabolism and disordersCholesterol and Lipid MetabolismDiabetes, Cardiovascular Risks, and LipoproteinsAtherosclerosis and Cardiovascular Diseases

Mutaz Al-Khnifsawi works in Lipoproteins and Cardiovascular Health, Lipid metabolism and disorders, Cholesterol and Lipid Metabolism, Diabetes, Cardiovascular Risks, and Lipoproteins, Atherosclerosis and Cardiovascular Diseases. Recorded institutional associations include University of Al-Qadisiyah.

28Publications

1,445Citations

12H-index

ORCID

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

← Return to the university profile

Mutaz Al-Khnifsawi

University of Al-Qadisiyah

Selected research works

Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Reducing the Clinical and Public Health Burden of Familial Hypercholesterolemia

Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study

Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

Clinical staging to guide management of metabolic disorders and their sequelae: a European Atherosclerosis Society consensus statement

Nutraceutical approaches to non-alcoholic fatty liver disease (NAFLD): A position paper from the International Lipid Expert Panel (ILEP)

Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

Sex Differences in Diagnosis, Treatment, and Cardiovascular Outcomes in Homozygous Familial Hypercholesterolemia

Overweight, obesity, and cardiovascular disease in heterozygous familial hypercholesterolaemia: the EAS FH Studies Collaboration registry

Familial hypercholesterolaemia in children and adolescents: a European Atherosclerosis Society consensus statement

Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis

The Effect of PCSK9 Inhibitors on LDL-C Target Achievement in Patients with Homozygous Familial Hypercholesterolemia: A Retrospective Cohort Analysis

Modern approaches to the management of homozygous familial hypercholesterolemia in the Middle East and North Africa

A collaborative effort across Africa to investigate risk factors and outcomes of premature acute coronary syndrome: Protocol for the EAS Lipid Registry of Africa (LIPRA)

Lipid clinics worldwide: harmonization and guidance on how to optimally organize and fund. European Atherosclerosis Society consensus statement across 55 countries and more than 500 lipid clinics

Management of Children with Heterozygous Familial Hypercholesterolemia Worldwide: A Meta-Analysis.

Healthcare professional awareness and use of inflammation-based risk assessment in ASCVD: The CARDIO-INFLAME survey

Diagnosis, treatment and cardiovascular outcomes in homozygous familial hypercholesterolaemia: A sex-specific analysis

From the President of the International Atherosclerosis Society: The Iraqi Lipid Clinics Network

REAL-WORLD PRACTICES FOR MANAGEMENT OF VERY YOUNG PATIENTS WITH HOMOZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA: A CLINICIAN SURVEY

Real-World Practices for Management of Very Young Patients with Homozygous Familial Hypercholesterolemia: A Clinician Survey

PREMARITAL FAMILIAL HYPERCHOLESTEROLEMIA SCREENING, A NEW HOPE FOR THE FAMILIES

Management of children with heterozygous familial hypercholesterolaemia worldwide: a meta-analysis